The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 22, 2019
Filed:
Jun. 03, 2016
Applicant:
Merrimack Pharmaceuticals, Inc., Cambridge, MA (US);
Inventors:
Olga Burenkova, Newton, MA (US);
Gavin MacBeath, Wakefield, MA (US);
Lin Nie, Needham Heights, MA (US);
Mark Sevecka, Cambridge, MA (US);
Assignee:
Merrimack Pharmaceuticals, Inc., Cambridge, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/32 (2006.01); C12Q 1/6886 (2018.01); C07K 16/30 (2006.01); G01N 33/574 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/32 (2013.01); C07K 16/30 (2013.01); C07K 16/3015 (2013.01); C07K 16/3023 (2013.01); C07K 16/3069 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57407 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/52 (2013.01);
Abstract
Methods for predicting a therapeutic response in a patient (e.g., a cancer patient) to ErbB3 inhibitors, and methods of treating a cancer patient with targeted therapies.